`
Monday, 26 June 2017

Drug Discovery News

  • Sosei' subsidiary Heptares records positive outcome of Schizophrenia drug

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 12 Feb, 2016

    Sosei Group Corporation has reported that Heptares Therapeutics, the wholly-owned subsidiary of Japan's Sosei Group Corporation, has recorded positive findings from its phase Ib clinical st...Read more

  • FDA warns against Mitshubi Tanabe's type 2 diabetes drug

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2015

    Singapore: US Food and Drug Administration (FDA) has warned against type 2 diabetes medicine, canagliflozin (Invokana, Invokamet), developed by Japan's Mitsubishi Tanabe Pharma and marketed...Read more

  • Aussie anesthetic firm gets patent from 7 nations

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013

    Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in the UK, Australia, New Zealand, Hong Kong, Singapore and South Africa....Read more

  • Australia's TransBio, DendroCyte to develop antibody for transplant rejection

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 22 Sep, 2015

    Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and develop novel antibody therapeutics directed against CD83, a relative...Read more

  • Daiichi Sankyo files NDA for Prasugrel in Japan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013

    Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welfare in Japan for the antiplatelet agent Prasugrel for the treatment o...Read more

  • Orient launches prostate cancer drug in SE Asia

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 27 May, 2014

    Singapore: Orient EuroPharma, a specialty pharmaceutical company focused in marketing and commercialization has partnered with Debiopharm Group, Swiss-based global biopharmaceutical company...Read more

  • Innate Immunotherapeutics completes $9mn IPO

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2013

    Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that the company would channelize to commence planning its clinical trial...Read more

  • Cadila Healthcare eyeing US, Europe markets

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 15 Sep, 2014

    Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon start filings for approval of its innovator drug Lipaglyn there. As per ...Read more

  • Rock Creek granted Japanese, European, US Patent for lead compound

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 06 May, 2016

    Rock Creek Pharmaceuticals Inc, a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions, has announced r...Read more

  • Infect mosquitoes with Wolbachia, stop diseases

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2013

    Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected with the bacteria Wolbachia lose their ability to spread diseases such ...Read more

  • LabCorp launches 4th gen HIV antigen assay

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2013

    Singapore: Laboratory Corporation of America has released 4th generation HIV antigen/antibody combination assay and a new diagnostic algorithm for earlier detection of HIV that can improve ...Read more

  • FDA designates Chugai's bispecific antibody as breakthrough therapy

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2015

    Japan's pharma giant, Chugai Pharmaceutical Co. has reported that the US Food and Drug Administration (FDA) has granted the breakthrough therapy designation to 'ACE910' for the prophylactic...Read more

  • NZ gets drug that glows brain tumour

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2015

    Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove malignant brain tumours has been approved for marketing and distribution ...Read more

  • Singapore develops animal-free screening platform to predict nephrotoxicity

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2015

    Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-free screening platforms capable of predicting the toxic effects of com...Read more

  • Shionogi's constipation drug phase III study shows significant improvement

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2016

    The US subsidiary of Osaka-based Shionogi has announced results of its pivotal phase III study (COMPOSE I). The study revealed that its once-daily treatment with naldemedine significantly i...Read more

  • LBT Innovations inks partnership with French tech firm

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2015

    Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro diagnostics company, bioMérieux, for LBT's foundational culture pla...Read more

  • CARsgen partners with Shanghai Cancer Institute to develop cancer immunotherapies

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2015

    Singapore: China based CARsgen Therapeutics, a private and venture backed company focused on the development of CAR-T-based autologous immunotherapy to treat solid tumors, has partnered wit...Read more

  • Actavis to acquire Forest Lab

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2014

    Singapore: Actavis has recieved US Federal Trade Commission (FTC) nod to acquire Forest Laboratories following a proposed consent order, pursuant to which the companies have agreed to dives...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls